Bellicum is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever.
Aju IB Investment
Cancer Prevention and Research Institute of Texas
RA Capital Management
Genomic and Epigenominc Instabillity
Less than $1M
Register and Claim Ownership